Skip to main content

Addex Therapeutics Ltd (ADXN)

NASDAQ: ADXN · IEX Real-Time Price · USD
6.05
+0.20 (3.42%)
At close: Dec 29, 2023, 4:00 PM
6.00
-0.05 (-0.83%)
After-hours: Dec 29, 2023, 4:15 PM EST

Addex Therapeutics Revenue

Addex Therapeutics had revenue of $2.24M in the twelve months ending September 30, 2023, with 72.51% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $357.85K, a -17.36% decrease year-over-year. In the year 2022, Addex Therapeutics had annual revenue of $1.55M, a decrease of -55.16%.

Revenue (ttm)
$2.24M
Revenue Growth
+72.51%
P/S Ratio
4.11
Revenue / Employee
$93,393
Employees
24
Market Cap
9.20M USD

Revenue Chart

* The company reports in CHF currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20221.55M-1.91M
-55.16%
Dec 31, 20213.47M-942.95K
-21.39%
Dec 31, 20204.41M1.49M
50.90%
Dec 31, 20192.92M-3.92M
-57.29%
Dec 31, 20186.84M6.33M
1,233.43%
Dec 31, 2017512.92K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zhongchao 17.23M
Applied DNA Sciences 13.37M
Precipio 13.26M
Aravive 7.00M
Aeterna Zentaris 6.86M
Ainos 1.14M
ABVC BioPharma 739.26K
Revenue Rankings

ADXN News

More News